A recombinant vaccine of h5n1 ha1 fused with foldon and human igg fc induced complete cross-clade protection against divergent h5n1 viruses

HIGHLIGHTS

• who: Protection against Divergent H and collaborators from the Lindsley FKimball Research Institute, New York Blood Center, New York, New York, United States of America, Department of Microbiology, University of Hong Kong have published the research: A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses, in the Journal: (JOURNAL) of January/27,/2011
• what: The authors designed and constructed two recombinant influenza vaccine candidates by fusing hemagglutinin 1 (HA1) fragment of A/Anhui/1/2005(H5N1) to either Fc of human IgG . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.